TrianglePUBLICATIONS · 3478198
Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Eur J Cancer Clin Oncol
- Publication date
- 1987 Jul
- First author
- Lambertenghi-Deliliers G
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Lambertenghi-Deliliers G
- type
- Author
- name
- Maiolo AT
- type
- Author
- name
- Annaloro C
- type
- Author
- name
- Cortelezzi A
- type
- Author
- name
- Pogliani E
- type
- Author
- name
- Ganzina F
- type
- Author
- name
- Polli EE
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Lambertenghi-Deliliers G
- type
- Author
- name
- Maiolo AT
- type
- Author
- name
- Annaloro C
- type
- Author
- name
- Cortelezzi A
- type
- Author
- name
- Pogliani E
- type
- Author
- name
- Ganzina F
- type
- Author
- name
- Polli EE
- type
- Author
- bibliography ids
- nci-bib-138d29fdd1986cb0703ba2f3
- book metadata
- content sha256
- 5e36a8a36958413c2fdb9f1fe9a1e478d937b5b6597cf9b0a83a9f86996a16be
- document type
- citation
- dois
- 10.1016/0277-5379(87)90356-7
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:3478198
- immutable id
- pubmed:3478198@5e36a8a36958413c2fdb9f1fe9a1e478d937b5b6597cf9b0a83a9f86996a16be
- journal
- abbreviation
- Eur J Cancer Clin Oncol
- issn electronic
- Source null
- issn print
- 0277-5379
- issue
- 7
- name
- European journal of cancer & clinical oncology
- nlm unique id
- 8112045
- pages
- 1041-5
- volume
- 23
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 3478198
- provenance
- batch id
- a2059861e4099d0f54b4
- provider
- NCBI PubMed ESummary
- record sha256
- 42d486e0571eab557cbc159b1adf79f3a9d1bf2818e81db4c681a6b30015aa6f
- response sha256
- d338ccf62b1e9c7837730008fcd5c2d96e2453a423d7e449285b89d28e5a3bc3
- retrieved at
- 2026-09-09T23:45:12.786635+00:00
- publication date
- display
- 1987 Jul
- precision
- month
- year
- 1987
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/3478198/
- title
- Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia.
Preserved source evidence · Not medical advice